Both in Biotechnology
Hemab Therapeutics Holdings vs Vericel
Over the past year COAG returned +5.2% and VCEL returned +5.0%; their daily moves had a correlation of 0.23.
COAG +5.2% VCEL +5.0%Growth of $1, one year, split-adjusted
| Metric | COAG | VCEL |
|---|---|---|
| Price | $41.45 | $40.26 |
| Market cap | $1.94B | $2.06B |
| Today | +2.55% | −6.18% |
| 1 month | +33.5% | +2.1% |
| 6 months | — | +13.2% |
| Year to date | — | +11.8% |
| 1 year | — | +15.4% |
| Revenue growth (YoY) | — | +22.5% |
| Gross margin | — | 72.8% |
| Net margin | — | 2.8% |
| P/E (TTM) | — | 85.1× |
| Price / sales | — | 6.7× |
| Net cash | $457.5M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 33.0% |
| Short % of float | 20.4% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).